Omega-7 oil increases telomerase activity and accelerates healing of grafted burn and donor site wounds.
3T3 Cells
Animals
Burns
/ drug therapy
Cell Line
Cell Movement
/ drug effects
Cell Proliferation
/ drug effects
Disease Models, Animal
Female
Fish Oils
/ pharmacology
Hippophae
/ metabolism
Keratinocytes
/ drug effects
Mice
Re-Epithelialization
/ drug effects
Sheep
Telomerase
/ metabolism
Tyrosine
/ analogs & derivatives
Wound Healing
/ drug effects
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 01 2021
13 01 2021
Historique:
received:
19
02
2020
accepted:
10
12
2020
entrez:
14
1
2021
pubmed:
15
1
2021
medline:
13
8
2021
Statut:
epublish
Résumé
This study investigated the efficacy of Omega-7 isolated from the sea buckthorn oil (Polyvit Co., Ltd, Gangar Holding, Ulaanbaatar, Mongolia) in ovine burn wound healing models. In vitro, proliferation (colony-forming rate) and migration (scratch) assays using cultured primary ovine keratinocytes were performed with or without 0.025% and 0.08% Omega-7, respectively. The colony-forming rate of keratinocytes in the Omega-7 group at 72 and 96 h were significantly higher than in the control (P < 0.05). The percentage of closure in scratch assay in the Omega-7 group was significantly higher than in the control at 17 h (P < 0.05). In vivo, efficacy of 4% Omega-7 isolated from buckthorn oil was assessed at 7 and 14 days in grafted ovine burn and donor site wounds. Telomerase activity, keratinocyte growth factor, and wound nitrotyrosine levels were measured at day 14. Grafted sites: Un-epithelialized raw surface area was significantly lower and blood flow was significantly higher in the Omega-7-treated sites than in control sites at 7 and 14 days (P < 0.05). Telomerase activity and levels of keratinocyte growth factors were significantly higher in the Omega-7-treated sites after 14 days compared to those of control (P < 0.05). The wound 3-nitrotyrosine levels were significantly reduced by Omega-7. Donor sites: the complete epithelialization time was significantly shorter and blood flow at day 7 was significantly higher in the Omega-7-treated sites compared to control sites (P < 0.05). In summary, topical application of Omega-7 accelerates healing of both grafted burn and donor site wounds. Omega-7 should be considered as a cost-efficient and effective supplement therapy for burn wound healing.
Identifiants
pubmed: 33441597
doi: 10.1038/s41598-020-79597-0
pii: 10.1038/s41598-020-79597-0
pmc: PMC7806965
doi:
Substances chimiques
Fish Oils
0
3-nitrotyrosine
3604-79-3
Tyrosine
42HK56048U
Telomerase
EC 2.7.7.49
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
975Références
Nat Cell Biol. 2000 Oct;2(10):737-44
pubmed: 11025665
Mater Sci Eng C Mater Biol Appl. 2018 Sep 1;90:227-235
pubmed: 29853086
Regen Ther. 2020 May 26;14:341-343
pubmed: 32490059
Burns. 2008 Feb;34(1):6-17
pubmed: 17905515
N Engl J Med. 1999 Sep 2;341(10):738-46
pubmed: 10471461
Plast Reconstr Surg. 2004 Apr 15;113(5):1347-54
pubmed: 15060346
Plast Reconstr Surg. 2018 Jul;142(1):217-226
pubmed: 29649056
Trends Biochem Sci. 2002 Jul;27(7):339-44
pubmed: 12114022
Annu Rev Genomics Hum Genet. 2009;10:45-61
pubmed: 19405848
Exp Dermatol. 2011 Apr;20(4):297-302
pubmed: 21371125
Burns. 2020 Dec;46(8):1914-1923
pubmed: 32513501
Ann Surg. 2000 Jun;231(6):869-76
pubmed: 10816630
J Orthop Res. 2011 Oct;29(10):1554-62
pubmed: 21469178
Nature. 1990 May 31;345(6274):458-60
pubmed: 2342578
Microsurgery. 2020 Jan;40(1):51-58
pubmed: 30666707
Ann Surg. 1988 Sep;208(3):313-20
pubmed: 3048216
Annu Rev Biochem. 1996;65:337-65
pubmed: 8811183
J Invest Dermatol. 1987 Dec;89(6):536-9
pubmed: 3119730
Front Biosci. 2007 May 01;12:2849-68
pubmed: 17485264
Burns. 2002 Feb;28(1):3-9
pubmed: 11834323
J Biol Chem. 2007 Mar 2;282(9):6001-11
pubmed: 17200110
Biochem Biophys Res Commun. 2020 May 21;526(1):141-146
pubmed: 32199614
Nat Commun. 2018 Jul 17;9(1):2784
pubmed: 30018305
Int J Biol Macromol. 2018 May;111:649-659
pubmed: 29339283
Evid Based Complement Alternat Med. 2011;2011:659705
pubmed: 19946025
Sci Rep. 2019 Jul 22;9(1):10564
pubmed: 31332199
Mol Reprod Dev. 2005 Feb;70(2):122-32
pubmed: 15570615
Wound Repair Regen. 2008 Sep-Oct;16(5):585-601
pubmed: 19128254
Burns. 2014 May;40(3):511-9
pubmed: 24007892
Adv Wound Care (New Rochelle). 2015 Apr 1;4(4):225-234
pubmed: 25945285
Biol Pharm Bull. 2002 Sep;25(9):1133-6
pubmed: 12230103
Free Radic Biol Med. 2020 Feb 20;148:162-169
pubmed: 31926882
J Microbiol Biotechnol. 2017 Jul 28;27(7):1257-1265
pubmed: 28535611
Nature. 2005 Aug 18;436(7053):1048-52
pubmed: 16107853
Lancet. 2003 Apr 19;361(9366):1345-6
pubmed: 12711471
J Dent Res. 2010 Mar;89(3):219-29
pubmed: 20139336
J Wound Care. 2013 Jan;22(1):7-8, 10, 12-6
pubmed: 23299352
Anal Biochem. 1985 Oct;150(1):76-85
pubmed: 3843705
Plast Reconstr Surg. 2005 Aug;116(2):539-45
pubmed: 16079688
Hell J Nucl Med. 2009 Jan-Apr;12(1):55-8
pubmed: 19330185
J Biotechnol. 2020 Feb 20;310:103-113
pubmed: 32023480
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Lancet. 2016 Oct 1;388(10052):1437-1446
pubmed: 27707500
Food Chem Toxicol. 2009 Jun;47(6):1146-53
pubmed: 19425187
Arch Dermatol Res. 2014 Sep;306(7):601-17
pubmed: 24895176
Cell. 2003 Jul 25;114(2):241-53
pubmed: 12887925
Oxid Med Cell Longev. 2016;2016:4692486
pubmed: 26933473
World J Surg. 2004 Mar;28(3):321-6
pubmed: 14961191